Search research articles
Contact Us
Filters
Showing results (111-120 of 120) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 120 results.
Journal of Robotic Surgery
|
May 6, 2020
Oncologic outcomes of patients with incidental prostate cancer who underwent RARC: a comparison between nerve sparing and non-nerve sparing approach
F Chessa, A Möller, J Collins, et al.
Cell Death & Disease
|
January 27, 2012
Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells
P Kharaziha, P Rodriguez, Q Li, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 5, 2016
Pursuing Quality in the Application of Bladder Cancer Quality of Life Research
N E Mohamed, F Gilbert, C T Lee, et al.
The Review of Scientific Instruments
|
November 4, 2011
Compact x-ray microradiograph for in situ imaging of solidification processes: bringing in situ x-ray micro-imaging from the synchrotron to the laboratory
C Rakete, C Baumbach, A Goldschmidt, et al.
European Urology Open Science
|
August 2, 2021
Corrigendum to "A standard operating technique to facilitate early return of urinary continence after robotic prostatectomy outcomes of a consensus meeting of experts with experience of over 30,000 cases" [Eur Urol Suppl 2017;16;e2301-2]
A N Sridhar, P Sooriakumaran, P Rajan, et al.
Oncogene
|
November 19, 2013
N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype
H C Whitaker, L L Shiong, J D Kay, et al.
The Journal of Urology
|
November 5, 2019
Reply by Authors
A A Hussein, A S Elsayed, N A Aldhaam, et al.
Cell Communication and Signaling : CCS
|
July 21, 2021
Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease
M Archer, N Dogra, Z Dovey, et al.
Biorxiv : the Preprint Server for Biology
|
September 16, 2024
HLA-E and NKG2A Mediate Resistance to <i>M. bovis</i> BCG Immunotherapy in Non-Muscle-Invasive Bladder Cancer
D Ranti, H Yu, Y A Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2019
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†
A Horwich, M Babjuk, J Bellmunt, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 120) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 120 results.
Journal of Robotic Surgery
|
May 6, 2020
Oncologic outcomes of patients with incidental prostate cancer who underwent RARC: a comparison between nerve sparing and non-nerve sparing approach
F Chessa, A Möller, J Collins, et al.
Cell Death & Disease
|
January 27, 2012
Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells
P Kharaziha, P Rodriguez, Q Li, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 5, 2016
Pursuing Quality in the Application of Bladder Cancer Quality of Life Research
N E Mohamed, F Gilbert, C T Lee, et al.
The Review of Scientific Instruments
|
November 4, 2011
Compact x-ray microradiograph for in situ imaging of solidification processes: bringing in situ x-ray micro-imaging from the synchrotron to the laboratory
C Rakete, C Baumbach, A Goldschmidt, et al.
European Urology Open Science
|
August 2, 2021
Corrigendum to "A standard operating technique to facilitate early return of urinary continence after robotic prostatectomy outcomes of a consensus meeting of experts with experience of over 30,000 cases" [Eur Urol Suppl 2017;16;e2301-2]
A N Sridhar, P Sooriakumaran, P Rajan, et al.
Oncogene
|
November 19, 2013
N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype
H C Whitaker, L L Shiong, J D Kay, et al.
The Journal of Urology
|
November 5, 2019
Reply by Authors
A A Hussein, A S Elsayed, N A Aldhaam, et al.
Cell Communication and Signaling : CCS
|
July 21, 2021
Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease
M Archer, N Dogra, Z Dovey, et al.
Biorxiv : the Preprint Server for Biology
|
September 16, 2024
HLA-E and NKG2A Mediate Resistance to <i>M. bovis</i> BCG Immunotherapy in Non-Muscle-Invasive Bladder Cancer
D Ranti, H Yu, Y A Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2019
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†
A Horwich, M Babjuk, J Bellmunt, et al.
Page
of 12